ARCH Venture Partners X
Major shareholder at Neumora Therapeutics · 2 reported transactions in 2 companies · latest trade Oct 27, 2025
Their record
Across their whole record, 2 purchases can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move +9.7%, S&P 500 +10.9% over the same days.
Their trades
Bought | Oct 27, 2025 | Oct 27, 2025 close $2.69 → Oct 23, 2026 close $0.38. S&P 500 +10.9% over the same days. | ||
Bought | Aug 1, 2025 | Aug 1, 2025 close $4.04 → Oct 23, 2026 close $3.67. S&P 500 +22.2% over the same days. |
BoughtNeumora Therapeutics
$5M
Oct 27, 2025 close $2.69 → Oct 23, 2026 close $0.38. S&P 500 +10.9% over the same days.
BoughtPrime Medicine
$10M
Aug 1, 2025 close $4.04 → Oct 23, 2026 close $3.67. S&P 500 +22.2% over the same days.